AAAAAA

   
Results: 1-10 |
Results: 10
LOW RELATIVE FREQUENCIES OF CD26(-TERM NONPROGRESSING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED SUBJECTS() CD4(+) CELLS IN LONG)
Authors: BROSTROM C SONNERBORG A LINDBACK S GAINES H
Citation: C. Brostrom et al., LOW RELATIVE FREQUENCIES OF CD26(-TERM NONPROGRESSING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED SUBJECTS() CD4(+) CELLS IN LONG), Clinical and diagnostic laboratory immunology, 5(5), 1998, pp. 662-666
CHARACTERIZATION OF THE VIRAL POPULATION DURING PRIMARY HIV-1 INFECTION
Authors: KARLSSON AC LINDBACK S GAINES H SONNERBORG A
Citation: Ac. Karlsson et al., CHARACTERIZATION OF THE VIRAL POPULATION DURING PRIMARY HIV-1 INFECTION, AIDS, 12(8), 1998, pp. 839-847
ROUTE OF TRANSMISSION DETERMINES DEVELOPMENT OF HIV DISEASE
Authors: PEHRSON PO LINDBACK S LIDMAN C GAINES H GIESECKE J
Citation: Po. Pehrson et al., ROUTE OF TRANSMISSION DETERMINES DEVELOPMENT OF HIV DISEASE, AIDS, 12(3), 1998, pp. 324-325
EVALUATION OF 14 COMMERCIAL HIV-1 HIV-2 ANTIBODY-ASSAYS USING SERUM PANELS OF DIFFERENT GEOGRAPHICAL ORIGIN AND CLINICAL STAGE INCLUDING A UNIQUE SEROCONVERSION PANEL/
Authors: THORSTENSSON R ANDERSSON S LINDBACK S DIAS F MHALU F GAINES H BIBERFELD G
Citation: R. Thorstensson et al., EVALUATION OF 14 COMMERCIAL HIV-1 HIV-2 ANTIBODY-ASSAYS USING SERUM PANELS OF DIFFERENT GEOGRAPHICAL ORIGIN AND CLINICAL STAGE INCLUDING A UNIQUE SEROCONVERSION PANEL/, Journal of virological methods, 70(2), 1998, pp. 139-151
SKIN AND MUCOSAL CHARACTERISTICS OF SYMPTOMATIC PRIMARY HIV-1 INFECTION
Authors: LAPINS J GAINES H LINDBACK S LIDBRINK P EMTESTAM L
Citation: J. Lapins et al., SKIN AND MUCOSAL CHARACTERISTICS OF SYMPTOMATIC PRIMARY HIV-1 INFECTION, AIDS patient care, 11(2), 1997, pp. 67-70
LONGER SURVIVAL AFTER HIV-INFECTION FOR INJECTING DRUG-USERS THAN FORHOMOSEXUAL MEN - IMPLICATIONS FOR IMMUNOLOGY
Authors: PEHRSON P LINDBACK S LIDMAN C GAINES H GIESECKE J
Citation: P. Pehrson et al., LONGER SURVIVAL AFTER HIV-INFECTION FOR INJECTING DRUG-USERS THAN FORHOMOSEXUAL MEN - IMPLICATIONS FOR IMMUNOLOGY, AIDS, 11(8), 1997, pp. 1007-1012
MUCOCUTANEOUS MANIFESTATIONS IN 22 CONSECUTIVE CASES OF PRIMARY HIV-1INFECTION
Authors: LAPINS J LINDBACK S LIDBRINK P BIBERFELD P EMTESTAM L GAINES H
Citation: J. Lapins et al., MUCOCUTANEOUS MANIFESTATIONS IN 22 CONSECUTIVE CASES OF PRIMARY HIV-1INFECTION, British journal of dermatology, 134(2), 1996, pp. 257-261
DOES SYMPTOMATIC PRIMARY HIV-1 INFECTION ACCELERATE PROGRESSION TO CDC STAGE-IV DISEASE, CD4 COUNT BELOW 200 X 10(6) 1, AIDS, AND DEATH FROM AIDS/
Authors: LINDBACK S BROSTROM C KARLSSON A GAINES H
Citation: S. Lindback et al., DOES SYMPTOMATIC PRIMARY HIV-1 INFECTION ACCELERATE PROGRESSION TO CDC STAGE-IV DISEASE, CD4 COUNT BELOW 200 X 10(6) 1, AIDS, AND DEATH FROM AIDS/, BMJ. British medical journal, 309(6968), 1994, pp. 1535-1537
AEROSOLIZED PENTAMIDINE AS PRIMARY PROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA - EFFICACY, MORTALITY AND MORBIDITY
Authors: LIDMAN C BERGLUND O TYNELL E LINDBACK S ELVIN K
Citation: C. Lidman et al., AEROSOLIZED PENTAMIDINE AS PRIMARY PROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA - EFFICACY, MORTALITY AND MORBIDITY, AIDS, 8(7), 1994, pp. 935-939
AEROSOLIZED PENTAMIDINE VERSUS IV PENTAMIDINE FOR SECONDARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA
Authors: LIDMAN C TYNELL E BERGLUND O LINDBACK S
Citation: C. Lidman et al., AEROSOLIZED PENTAMIDINE VERSUS IV PENTAMIDINE FOR SECONDARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA, Infection, 21(3), 1993, pp. 146-149
Risultati: 1-10 |